key: cord-0883983-0kxail2v
authors: nan
title: 病毒性肺炎的流行对肺癌患者的影响和思考
date: 2020-04-20
journal: Zhongguo Fei Ai Za Zhi
DOI: 10.3779/j.issn.1009-3419.2020.102.13
sha: e21515016c5070c5ddabe94c8c887894fcdc582f
doc_id: 883983
cord_uid: 0kxail2v

The worldwide epidemic of three coronaviruses and one influenza virus in 21(st) century have seriously threatened human health. Infection with these viruses can cause respiratory symptoms. The patients with lung cancer are more susceptible to viral infection and have a worse prognosis due to the advanced age and the systemic immunosuppressive state caused by malignancy itself and the anticancer treatments. In addition, without sufficient clinical awareness, a missed diagnosis of viral pneumonia may occur due to the fever and respiratory symptoms caused by lung cancer and its secondary diseases. Furthermore, control measures against viral outbreaks may interfere with routine diagnosis and treatment of lung cancer patients. Therefore, scientific protection and individualized management of lung cancer patients are particularly important during virus epidemic prevention and control. Here, we systematically reviewed the epidemiological and clinical characteristics of viral pneumonia, its impact on patients with lung cancer and the differential diagnosis of lung cancer-related respiratory manifestations, aiming to provide guidance for the individual management of lung cancer patients during the prevention and control of viral pneumonia epidemic.

Therefore, scientific protection and individualized management of lung cancer patients are particularly important during virus epidemic prevention and control. Here, we systematically reviewed the epidemiological and clinical characteristics of viral pneumonia, its impact on patients with lung cancer and the differential diagnosis of lung cancer-related respiratory manifestations, aiming to provide guidance for the individual management of lung cancer patients during the prevention and control of viral pneumonia epidemic. 【Key words】 Lung neoplasms; Viral pneumonia; Individualized management [29] Lung cancer history 

A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area

Clinical characteristics of coronavirus d i s e a s e 2 019 i n C h i n a

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Pulmonary pathology of early-phase 2019 novel coronavirus (COV ID-19) pneumonia in two patients with lung cancer

Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms

Ta le s f rom t he f ront l i ne: t he colorec t a l bat t le against SA RS

Impact of severe acute respiratory syndrome on patient access to palliative radiation therapy

Naproxen for the treatment of neoplastic fever: a PRISMA-compliant systematic review and metaanalysis

How we treat febrile neutropenia in patients receiving cancer chemotherapy

Post-obstructive pneumonia in patients with cancer: a review

Radiation pneumonitis

Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings

Drug-induced lung injury

Immune checkpoint inhibitor therapy-related pneumonitis: patterns and management